Meric-Bernstam F, Akcakanat A, Chen H, Do KA, Sangai T, Adkins F, Gonzalez-Angulo AM, Rahsid A, Crosby K, Dong M, Phan AT, Chang DZ, Wolff RA, Gupta S, Mills GB, Yao J. PIK3CA/PTEN mutations and AKT activation as markers of sensitivity to allosteric mTOR inhibitors. Clin Cancer Res. 2012 Mar 15;18(6):1777-89. - Stand Up To Cancer

Blog

Posted September 17, 2019

Meric-Bernstam F, Akcakanat A, Chen H, Do KA, Sangai T, Adkins F, Gonzalez-Angulo AM, Rahsid A, Crosby K, Dong M, Phan AT, Chang DZ, Wolff RA, Gupta S, Mills GB, Yao J. PIK3CA/PTEN mutations and AKT activation as markers of sensitivity to allosteric mTOR inhibitors. Clin Cancer Res. 2012 Mar 15;18(6):1777-89.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.